Prevalence and predictors of thyroid dysfunction amongst patients with Type 2 diabetes mellitus in Pakistan

被引:5
作者
Bukhari, Syeda Iffat [1 ]
Ali, Gohar [1 ]
Memom, Muhammad Yahya [1 ]
Sandeelo, Nabiya [1 ]
Alvi, Haris [2 ]
Talib, Abu [1 ]
Ahmed, Imtiaz [1 ]
Lal, Hari [1 ]
Asghar, Muhammad Sohaib [2 ]
Naseer, Ushna [3 ]
机构
[1] Dow Univ Hlth Sci, Dr Ruth KM Pfau Civil Hosp Karachi, Dept Internal Med, Karachi, Pakistan
[2] Dow Univ Hlth Sci, Dow Univ Hosp Ojha Campus, Dept Internal Med, Karachi, Pakistan
[3] Karachi Univ, Karachi Med & Dent Coll, Dept Internal Med, Karachi, Pakistan
关键词
FT3; FT4; hyperthyroidism; hypothyroidism; thyroid dysfunction; TSH; type II diabetes mellitus; POPULATION; ANTIBODIES; HEALTH;
D O I
10.4103/jfmpc.jfmpc_2106_21
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction:Diabetes and thyroid disorders are the two most common disorders amongst endocrine diseases. Uncontrolled diabetes mellitus (DM) may disturb thyroid metabolism by disturbing the levels of thyroid hormones in the plasma. This study was undertaken to determine the prevalence and thyroid dysfunction in type 2 diabetic population presenting in a public sector tertiary care teaching hospital. Materials and Methods:This descriptive cross-sectional study was conducted in Civil Hospital Karachi (CHK) in the department of medicine from October 01, 2018, to March 31, 2019. The study population consisted of 317 patients diagnosed with DM type 2 based on American Diabetes Association (ADA) criteria. Patients with fasting blood sugar >= 126 mg/dL, or HbA1c >6.5 (%), and 2 h postprandial blood glucose levels >200 mg/dL were included. After a minimum of 8 h of fasting, plasma samples of patients were collected and sent for fasting blood glucose, HbA1c, FT3, FT4, and thyroid-stimulating hormone (TSH). Descriptive statistics were calculated. Post-stratification Chi-squared test was applied, and a P value of <= 0.05 was considered significant. Results:Among all enrolled DM type 2 patients, 207 (65.3%) were male with a mean age of 46.54 +/- 8.72 years. Mean fasting blood sugar (FBS), random blood sugar (RBS), and HbA1c were 212.76 +/- 26.91 (mg/dL), 328.89 +/- 52.89 (mg/dL), and 9.43 +/- 2.47 (%), respectively. The mean duration of DM was 7.81 +/- 3.15 years. Mean FT3, FT4, and TSH were 113.13 +/- 44.40 (ng/dL), 7.63 +/- 3.11 (mg/dL) and 2.64 +/- 2.57 (mIU/mL), respectively. In the present study, 55 (17.4%) patients had subclinical hypothyroidism, 27 (8.5%) had hypothyroidism, 19 (6.0%) had hyperthyroidism, and 16 (5.0%) had subclinical hyperthyroidism. Significant association of thyroid dysfunction was established with age group, female gender, and family history of thyroid dysfunction (P =< 0.001). Conclusion:The prevalence of thyroid dysfunction is higher among patients with type 2 diabetes mellitus (T2DM), in which hypothyroidism was the most common dysfunction with more prevalence among female patients.
引用
收藏
页码:2739 / 2743
页数:5
相关论文
共 27 条
  • [1] Ahmed AshrafAhmed., 2017, INT J CLIN EXPT MEDI, V3, P1
  • [2] Aljabri KS., 2019, Arch Diabetes Obes, V2
  • [3] [Anonymous], 2021, Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes2018
  • [4] [Anonymous], 2021, IDF Diabetes Atlas 9th edition 2019. Diabetesatlas.org
  • [5] Bhusal K., 2018, J CollMed SciNepal, V14, P206
  • [6] Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population.: The Health Study of Nord-Trondelag (HUNT)
    Bjoro, T
    Holmen, J
    Krüger, O
    Midthjell, K
    Hunstad, K
    Schreiner, T
    Sandnes, L
    Brochmann, H
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) : 639 - 647
  • [7] The interface between thyroid and diabetes mellitus
    Duntas, Leonidas H.
    Orgiazzi, Jacques
    Brabant, Georg
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 75 (01) : 1 - 9
  • [8] Thyroid dysfunction prevalence and relation to glycemic control in patients with type 2 diabetes mellitus
    Elgazar, Essmat Hassan
    Esheba, Noha Elsayed
    Shalaby, Safenaz Alsaeed
    Mohamed, Wael Farrag
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2513 - 2517
  • [9] Elmenshawi IM., 2017, J DiabetesMetabDisord Control, V4, P55, DOI DOI 10.15406/JDMDC.2017.04.00106
  • [10] The Incidence and Prevalence of Thyroid Dysfunction in Europe: A Meta-Analysis
    Garmendia Madariaga, Ane
    Santos Palacios, Silvia
    Guillen-Grima, Francisco
    Galofre, Juan C.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (03) : 923 - 931